PRESS RELEASE : AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections
A new class of molecules with a novel resistance-breaking mode of action and the potential to replace common antibiotics Artilysins are able to pass the protective outer membrane of Gram-negative...
Source: marketscreener.com